原发性甲状腺淋巴瘤:一种罕见的诊断,可以用Polatuzumab Vedotin治疗
Rupam Sharma1,2, Arin Orogian1, Ralph Garcia-Pacheco1
1Department of Medicine, Kern Medical, Bakersfield, CA, USA.
Journal of investigative medicine high impact case reports
|November 16, 2024
概括
初级甲状腺淋巴瘤是一种罕见的癌症,通常会影响老年女性,呈现为快速增长的质量. 这项研究报告了第一个使用Pola-R-CHP治疗的扩散性大B细胞淋巴瘤病例.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 病理学 病理学 病理学
背景情况:
- 初级甲状腺淋巴瘤是一种罕见的额外淋巴瘤,占甲状腺恶性瘤的<5%.
- 它主要影响到老年人,特别是女性,呈现出快速的甲状腺质量增长和压缩症状.
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K